JoVE Logo

Zaloguj się

Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.

W tym Artykule

  • Podsumowanie
  • Streszczenie
  • Wprowadzenie
  • Protokół
  • Wyniki
  • Dyskusje
  • Ujawnienia
  • Podziękowania
  • Materiały
  • Odniesienia
  • Przedruki i uprawnienia

Podsumowanie

Presented here is a protocol for the fabrication of iron oxide nanoparticle-shelled microbubbles (NSMs) through self-assembly, synergizing magnetic, acoustic, and optical responsiveness in one nanotherapeutic platform for magnetic hyperthermia and photothermal combination cancer therapy.

Streszczenie

The precision delivery of anti-cancer agents which aim for targeted and deep-penetrated delivery as well as a controlled release at the tumor site has been challenged. Here, we fabricate iron oxide nanoparticle shelled microbubbles (NSMs) through self-assembly, synergizing magnetic, acoustic, and optical responsiveness in one nanotherapeutic platform. Iron oxide nanoparticles serve as both magnetic and photothermal agents. Once intravenously injected, NSMs can be magnetically guided to the tumor site. Ultrasound triggers the release of iron oxide nanoparticles, facilitating the penetration of nanoparticles deep into the tumor due to the cavitation effect of microbubbles. Thereafter, magnetic hyperthermia and photothermal therapy can be performed on the tumor for combinational cancer therapy, a solution for cancer resistance due to the tumor heterogeneity. In this protocol, the synthesis and characterization of NSMs including structural, chemical, magnetic and acoustic properties were performed. In addition, the anti-cancer efficacy by thermal therapy was investigated using in vitro cell cultures. The proposed delivery strategy and combination therapy holds great promise in cancer treatment to improve both delivery and anticancer efficacies.

Wprowadzenie

Cancer is one of the deadliest diseases, causing millions of deaths every year worldwide and huge economic losses1. In clinics, conventional anticancer therapies, such as surgical resection, radiotherapy, and chemotherapy still cannot provide a satisfactory therapeutic efficacy2. Limitations of these therapies are high toxic side effects, high recurrence rate and high metastasis rate3. For example, chemotherapy is suffered from the low delivery efficiency of chemo drugs precisely to the tumor site4. The inability of drugs to penetrate deep into the tumor tissue across the biological barriers, including extracellular matrix and high tumor interstitial fluid pressure, is also responsible for the low therapeutic efficacy5. Besides, the tumor resistance usually happens in the patients who received treatment by single chemotherapy6. Therefore, techniques where thermal ablation of tumor occurs, such as photothermal therapy (PTT) and magnetic hyperthermia therapy (MHT), have shown promising results to reduce tumor resistance and have been emerging in clinical trials7,8,9.

PTT triggers thermal ablation of cancer cells by the action of photothermal conversion agents under the irradiation of the laser energy. The generated high temperature (above 50 ˚C) induces complete cell necrosis10. Very recently, iron oxide nanoparticles (IONPs) were demonstrated to be a photothermal conversion agent that can be activated by near-infrared (NIR) light11.  Despite the low molar absorption coefficient in the near infrared region, IONPs are candidates for low-temperature (43  ˚C) photothermal therapy, a modified therapy to reduce the damage caused by heat exposure to normal tissues and to initiate antitumor immunity against tumor metastasis12. One of the limitations of PTT is the low penetration depth of the laser. For deep seated tumors, alternating magnetic field (AFM) induced heating of iron oxide nanoparticles, also called magnetic hyperthermia, is an alternative therapy for PTT13,14. The main advantage of MHT is the high penetration of magnetic field15. However, the required relatively high concentration of IONPs remains a major disadvantage for its clinical application. The delivery efficiency of nanomedicine (or nanoparticles) to solid tumors in animals has been 1-10% due to a series of obstacles including circulation, accumulation, and penetration16,17. Therefore, a controlled and targeted IONPs delivery strategy with the ability to achieve high tissue penetration is of great interest in cancer treatment.

Ultrasound mediated nanoparticle delivery has shown its ability to facilitate the penetration of nanoparticles deep into the tumor tissue, due to the phenomenon called microbubble cavitation18,19. In the present study, we fabricate IONPs shelled microbubbles (NSMs) through self-assembly, synergizing magnetic, acoustic, and optical responsiveness in one nanotherapeutic platform. The NSM contains an air core and a shell of iron oxide nanoparticles, with a diameter of approximately 5.4 µm. The NSMs can be magnetically guided to the tumor site. Then the release of IONPs is triggered by ultrasound, accompanied by microbubble cavitation and microstreaming. The momentum received from the microstreaming facilitates the penetration of IONPs into the tumor tissue. The PTT and MHT can be achieved by NIR laser irradiation or AFM application, or with the combination of both.

Protokół

All animal experiments were performed in accordance with the protocols approved by the OG Pharmaceutical guidelines for Animal Care and Use of Laboratory Animals. The protocols followed the guidelines of Ethics Committee for laboratory animals of OG Pharmaceutical.

1. Nanoparticle shelled microbubbles (NSMs) synthesis

  1. Disperse magnetic nanoparticles (Fe3O4, iron oxide) in deionized water to form a 10 mg/mL stock solution.
  2. Place the tube containing the IONPs solution in an ultrasonic cleaning machine for 20 min. Obtain a uniformly dispersed IONPs solution before use.
  3. Add 150 μL of deionized water, 150 μL of 10 mM sodium dodecyl sulfate (SDS), and 400 μL of a stock solution of IONPs from step 1.1. in 1.5 mL centrifuge tube. 
  4. Fix the homogenizer with a scaffold in an ice bath.
  5. Place the tube of the mixture in an ice bath and position the homogenizer probe precisely to be immersed in the mixture solution.
  6. Adjust the homogenizer speed to 20,000 rpm and turn on the homogenizer for 3 min.
  7. Turn off the homogenizer and remove the tube from the ice bath.
  8. Place the tube to the tube rack for 12 h stabilization at room temperature.
  9. Adsorb the resulted NSMs to the tube wall by a magnet and remove the supernatant. Then replenish with 1 mL of fresh deionized water.
  10. Repeat the wash process for three times and re-suspend NSMs in 1 mL of fresh distilled water.
  11. Transfer 10 μL of NSMs suspension to a clean glass slide after slightly shaking.
  12. Use a fluorescence microscope at 20x magnification to visualize NSMs morphology. Ensure taking photos at random area.
  13. Measure the diameter of the NSMs from the photos using an open access Nano Measurer 1.2 software. Count at least 200 microbubbles.
    1. Click “File” and “Open” to select the image file to be processed. After the image is imported, press the “ruler”. Draw a red line with the same length as the ruler.
    2. Then press “Settings|Ruler” and enter the length of the ruler. Draw lines of the same lengths as the diameters of the individual microbubbles in the image. Complete all the measurements, then click on “Report| View Report”.

2. Acoustic response of NSMs

  1. Dilute 200 μL of NSMs with 800 μL deionized water, then transfer into a 1.5 mL centrifuge tube to form a stock solution.
  2. Connect the function generator, amplifier, impedance matching, and homemade focused transducer. Place the transducer in the center at the bottom of the artificial cuboid sink and connect the hydrophone with an oscilloscope to monitor the output ultrasound intensity (Figure 1). Add deionized water into the sink to immerse the transducer.
  3. Adjust the function generator to the sweep mode, tune the frequency range from 10 kHz to 900 kHz and set the amplitude to 20 Vpp (Voltage peak-peak). Adjust the power of ultrasound to 0.1% by the amplifier. Each cycle’s duration is 4 s with a time interval of 1 s.
  4. Prepare 1 mL NSMs stock solution samples in the tube and fix the tube with a scaffold on the top of the homemade focused transducer. Attach the magnet to the bottom of the tube and attract the NSMs.
  5. Turn on the power of the function generator and the amplifier. Switch off the function generator after application of 5 cycles (25 s) of ultrasound. Remove the magnet and collect 1 mL of the solution containing the released IONPs. Add 1 mL of deionized water to the centrifuge tube.
  6. Repeat step 2.5. until NSMs in the tube collapse completely.
  7. Quantify all the released IONPs by the inductively coupled plasma optical emission spectrometry (ICP-OES) as described previously13.

3. Optical response of NSMs

NOTE: In this work, a laser system containing 808 nm laser power and an infrared thermal imaging camera previously described by Xu et al. is utilized20.

  1. Laser system preparation
    1. Turn on the power supply of the laser and allow it to warm for several minutes. Fix a fiber coupled 808 nm laser diode on a retort stand.
    2. Direct the laser beam to the sample stage through an optical fiber and focus on the sample stage to achieve a 6 mm light spot (in diameter) by a convex lens.
    3. Measure the power output with a laser power meter and adjust the power to 1 W/cm2.
    4. Fix the infrared thermal imaging camera on the tripod. Turn on the camera and check the if working (e.g., monitor the focused region of interest (ROI) temperature). Turn off the power supply and the infrared thermal imaging camera.
  2. Photothermal measurement in aqueous solution
    1. Prepare the 1 mL sample at different IONPs concentration (1.05 mg/mL, 1.35 mg/mL, 3.65 mg/mL, 5 mg/mL) in a 1.5 mL centrifuge tube.
    2. Place the tube of interest at the focused region of the laser beam and record the baseline temperature of the sample.
    3. Turn on the laser power and the infrared thermal imaging camera and irradiate the sample for 10 min continuously. At the same time, record the temperature in real time.
    4. Turn off the laser power and infrared thermal imaging camera after 10 min of irradiation. Wait for the temperature of the region to return to the baseline.
    5. Repeat 3.2.2 to 3.2.4 for the measurement of other samples.
      NOTE: Use deionized water at 20 °C as a control for the photothermal measurement.
  3. Photothermal measurement in cultured cells
    NOTE: Murine breast cancer cells (4T1) were selected as a model to investigate the inhibition effect by photothermal treatment.
    1. Feed the cells with Roswell Park Memorial Institute-1640 (RPMI-1640) medium supplemented with 10% fetal bovine serum (FBS) and 1% penicillin. Set the culturing environment as 37 °C and 5% CO2.
    2. Culture 4T1 cells in T25 flasks and passage the cells in a 1:2 ratio when 90% confluence is reached.
      NOTE: The subculture ratio can be adjusted according to the specific cell conditions in different labs.
    3. Remove and discard the culture medium. Rinse the cell layer with 1x PBS solution to remove the residual serum containing trypsin inhibitor.
    4. Add 2 mL of Trypsin-EDTA solution (0.25%) to the flask for detachment. Then add 3 mL of 1640 medium and aspirate cells by gently pipetting.
    5. Collect 5 mL of the cell suspension and centrifuge at 500 x g for 3 min.
    6. Remove the supernatant and add 1 mL of fresh 1640 medium to form a cell suspension.
    7. Add 100 μL of the cell suspension to a confocal dish containing 1 mL of the culture medium. Ensure that the concentration of cell suspension is 9 x 105/mL, and the final cell concentration in cell culture confocal dish is 8.1 x 104/mL.
    8. Place the inoculated cell culture confocal dish in an incubator for 24 h.
    9. Dilute different concentration (1.05 mg/mL, 1.35 mg/mL, 3.65 mg/mL, 5 mg/mL) of the IONPs sample to make 1 mL solution with serum-free 1640 medium.
    10. Aspirate the culture medium from the confocal dish and add the prepared sample solution.
    11. Turn on the laser power. Focus the laser beam at the center of the dish and adjust the output power to 1 W/cm2. Turn on the infrared thermal imaging camera, irradiate the cells in the confocal dish for 10 min continuously. Record the temperature in real time for the focused region.
    12. Turn off the laser and infrared thermal imaging camera. Transfer the irradiated dish to the incubator for another 24 h.
    13. Remove and discard the culture medium, add 1 mL of the fresh culture medium in the confocal dish. Add 5 μL of Calcein-AM solution (1 mg/mL) into the dish.
    14. Incubate the confocal dish at 37 °C and 5% CO2 for 15 min. Rinse the cell layer with 1x PBS solution twice.
    15. Observe and image the cells by a confocal fluorescence microscope with an excitation wavelength of 488 nm and an emission wavelength of 500-540 nm.
    16. Choose 5 areas in the confocal images randomly and count the number of live 4T1 cells in each area manually. Quantify the viability of 4T1 cells by comparing the number of live cells in all experimental groups with the control group.
      NOTE: Use the serum-free 1640 medium at 20 °C as a control for the photothermal measure. Use the sample without laser irradiation as cell viability control group.
  4. Photothermal measurement in vivo
    1. Prepare 3 of 8-week-old ICR male mice with a mean weight of 25 ± 2 g.
    2. Add 2 g of gelatin powder to 20 mL of deionized water. Heat the solution to 40 - 50 °C, dissolve the gelatin gel completely to form a transparent and clear solution.
    3. Add 100 mg IONPs to the solution from 3.4.2.
    4. Heat the gel to 40 – 50 °C, immediately inject 500 μL of the gelatin solution into the right breast pad of the mouse.
    5. Turn on the laser power and focus the laser beam at the interest region (right breast pad of the mice). Adjust the output power to 1 W/cm2. Turn on the infrared thermal imaging camera, irradiate the interest region for 10 min continuously. Record the temperature of the region of interest in real time.
    6. Turn off the laser and infrared thermal imaging camera.
    7. Euthanize mice by CO2 asphyxiation and cervical vertebra dislocation or any method approved by the Institute’s animal research committee.

4. Magnetic hyperthermia measurement

NOTE: Here, a magnetic hyperthermia system previously described by Wu et al. is utilized (21).

  1. Prepare a magnetic hyperthermia system include an alternating magnetic field (AFM) generator and an infrared thermal imaging camera.
    1. Turn on the chiller for 10 min and then power on the moderate radio frequency heating machine (i.e., AFM generator).
    2. Set the parameters of the machine as follows: frequency (f) = 415 kHz, magnetic field intensity = 1.8 kA/m.
  2. Magnetic hyperthermia measurement in aqueous solution
    1. Prepare 1 mL of the sample at different IONPs concentration (1.05 mg/mL, 1.35 mg/mL, 3.65 mg/mL, 5 mg/mL) in a 1.5 mL centrifuge tube.
    2. Place the tube in the center of a water-cooled magnetic induction copper coil.
    3. Turn on the alternating magnetic field (AFM) and the infrared thermal imaging camera. Induce the sample for 10 min continuously and record the temperature in real time.
      NOTE: The camera is located at the top of the sample, supplying a cross-sectional view of the sample.
    4. Turn off the AFM and the infrared thermal imaging camera. Wait for the temperature of the copper coil to come back to the baseline for 10 min.
      NOTE: Be careful of high temperature, avoid direct contact with hands and wait for cooling before removing samples.
    5. Repeat 4.2.2 to 4.2.4 for the measurement of the other samples.
    6. Power off the moderate radio frequency heating machine (AFM) and chiller.
      NOTE: Use the deionized water at 20 °C as a control for magnetic hyperthermia measurement.
  3. Magnetic hyperthermia measurement in vivo
    1. Prepare 3 of 8-week-old ICR male mice with a mean weight of 25 ± 2 g.
    2. Prepare 20 mL of 10 % gelatin gel containing 5 mg/mL IONPs solution.
    3. Heat the gelatin gel to 40 - 50 °C, immediately inject 500 μL of the gelatin solution into the right breast pad of the animal.
      NOTE: Magnetic-induced hyperthermia experiments were conducted with the heating machine using the same parameters as the in vitro test.
    4. Turn on the alternating magnetic field (AFM) and the infrared thermal imaging camera. Place the right breast pad of the mice in the center of a water-cooled magnetic induction copper coil.
    5. Turn on the infrared thermal imaging camera, image the interest region (right breast pad of the mice) for 10 min continuously and record the temperature of the interest region in real time.
    6. Turn off the power switch of the machine and infrared thermal imaging camera after 10 min of induction. Wait for the temperature of the copper coil to return to the baseline for 10 min.
    7. Repeat 4.3.4 to 4.3.6 for the measurement of other samples.
    8. Power off the moderate radio frequency heating machine (AFM) and chiller.
      NOTE: Be careful of high temperature, avoid direct contact with hands and wait for cooling before removing samples.
    9. Euthanize mice by CO2 asphyxiation and cervical vertebra dislocation or any method approved by the Institute’s animal research committee.

Wyniki

The triple-responsive nanoparticle-shelled microbubbles (NSMs) used in this study were prepared by agitating the mixture of the surfactant and IONPs. The IONPs (50 nm) self-assembled at the interface of liquid and gas core, to form a densely packed magnetic shell. The morphology of NSMs is shown in Figure. 1A. The resulted NSMs presented a spherical shape and with an average diameter of 5.41 ± 1.78 μm (Figure 1B). The results indicated the NSMs were prepared successfully. When ...

Dyskusje

Here, we presented a protocol of fabricating iron oxide nanoparticle shelled microbubbles (NSMs) through self-assembly, synergizing magnetic, acoustic, and optical responsiveness in one nanotherapeutic platform. The IONPs were densely packed around the air core to form a magnetic shell, which can be controlled by the external magnetic field for targeting. Once delivered, the release of IONPs can be achieved by ultrasound trigger. The released IONPs can be activated by both NIR light and AFM for PTT and MHT, or the combin...

Ujawnienia

The authors have nothing to disclose.

Podziękowania

This work was supported by the National Natural Science Foundation of China (81601608) and NUPTSF (NY216024).

Materiały

NameCompanyCatalog NumberComments
808 nm laser powerChangchun New Industries Optoelectronics TechMDL-F-808-5W-18017023
Calcein-AMThermo Fisher SCIENTIFICC3099
Fetal bovine serumInvitrogen16000-044
Fluorescence MicroscopeOlympusIX71
Function generatorKeysight33500B series20 MHz, 2 channels with arbitrary waveform generation capability
Gelatin gelSigma9000-70-8
Heating machineShuangpingSPG-06- II
Homemade focused transducerFrequency=855, R-X=36.2W+5.8W, |Z|-θ=37W+8°
HomogenizerSCILOGEXD-1608000-30000 rpm
HydrophoneT&CNH1000
ICR male miceOG Pharmaceutical. Co. Ltd8-week-old
Inductively coupled plasma optical emission spectrometryPerkinElmer
Infrared thermal imaging camera.FLIRE50
Iron(II,III) oxideAlfa Aesar1317-61-950-100nm APS Powder
Laser power meterChangchun New Industries Optoelectronics Tech
OscilloscopeKeysightDSOX3054TBandwidth 500 MHz, Sampling Rate 5 GS/S, 4 channels
RF Power AmplifierT&CAG1020The signal source can also be connected to an external signal source. The gain can be adjusted from 0 to 100%. It has multiple functions such as frequency sweep, pulse, and triangle.
Roswell Park Memorial Institute-1640KeyGEN BioTECHKGM31800
Sodium dodecyl sulfateSigma151-21-3

Odniesienia

  1. Kievit, F. M., Zhang, M. Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers. Advanced Materials. 23 (36), 217-247 (2011).
  2. Wu, H., et al. Fe3O4-Based Multifunctional Nanospheres for Amplified Magnetic Targeting Photothermal Therapy and Fenton Reaction. ACS Biomaterials Science & Engineering. 5 (2), 1045-1056 (2018).
  3. Thorat, N. D., et al. Physically stimulated nanotheranostics for next generation cancer therapy: Focus on magnetic and light stimulations. Applied Physics Reviews. 6 (4), 041306 (2019).
  4. Sun, Q., Zhou, Z., Qiu, N., Shen, Y. Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization. Advanced Materials. 29 (14), 1606628 (2017).
  5. Minchinton, A. I., Tannock, I. F. Drug penetration in solid tumours. Nature Reviews Cancer. 6 (8), 583-592 (2006).
  6. Anchordoquy, T. J., et al. Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions. ACS Nano. 11 (1), 12-18 (2017).
  7. Cazares-Cortes, E., et al. Recent insights in magnetic hyperthermia: From the "hot-spot" effect for local delivery to combined magneto-photo-thermia using magneto-plasmonic hybrids. Advanced Drug Delivery Reviews. 138, 233-246 (2019).
  8. Espinosa, A., et al. of Iron Oxide Nanoparticles in Cancer Therapy: Amplification of Heating Efficiency by Magnetic Hyperthermia and Photothermal Bimodal Treatment. ACS Nano. 10 (2), 2436-2446 (2016).
  9. Rastinehad, A. R., et al. Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study. Proceedings of the National Academy of Sciences of the United States of America. 116 (37), 18590-18596 (2019).
  10. Sharma, S. K., Shrivastava, N., Rossi, F., Tung, L. D., Thanh, N. T. K. Nanoparticles-based magnetic and photo induced hyperthermia for cancer treatment. Nano Today. 29, 100795 (2019).
  11. Das, R., Rinaldi-Montes, N. Boosted Hyperthermia Therapy by Combined AC Magnetic and Photothermal Exposures in Ag/Fe3O4 Nanoflowers. ACS Applied Materials & Interfaces. 8 (38), 25162-25169 (2016).
  12. Yang, Y., et al. 1D Coordination Polymer Nanofibers for Low-Temperature Photothermal Therapy. Advanced Materials. 29 (40), 1703588 (2017).
  13. Curcio, A., et al. Iron Oxide Nanoflowers CuS Hybrids for Cancer Tri-Therapy: Interplay of Photothermal Therapy, Magnetic Hyperthermia and Photodynamic Therapy. Theranostics. 9 (5), 1288-1302 (2019).
  14. Espinosa, A., et al. Hyper)Thermia or Photothermia? Progressive Comparison of Iron Oxide and Gold Nanoparticles Heating in Water, in Cells, and In Vivo. Advanced Functional Materials. 28 (37), 1803660 (2018).
  15. Xu, C., et al. Magnetic Hyperthermia Ablation of Tumors Using Injectable Fe(3)O(4)/Calcium Phosphate Cement. ACS Applied Materials & Interfaces. 7 (3), 13866-13875 (2015).
  16. Wilhelm, S., et al. Analysis of nanoparticle delivery to tumours. Nature Reviews Materials. 1, 16014 (2016).
  17. Chen, H., Zhang, W., Zhu, G., Xie, J., Chen, X. Rethinking cancer nanotheranostics. Nature Reviews Materials. 2, (2017).
  18. Rapoport, N. Y., Kennedy, A. M., Shea, J. E., Scaife, C. L., Nam, K. H. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. Journal of Controlled Release : The Official Journal of the Controlled Release Society. 138 (3), 268-276 (2009).
  19. Gao, Y., et al. Controlled nanoparticle release from stable magnetic microbubble oscillations. NPG Asia Materials. 8 (4), 260 (2016).
  20. Bao, B., et al. Mussel-inspired functionalization of semiconducting polymer nanoparticles for amplified photoacoustic imaging and photothermal therapy. Nanoscale. 11 (31), 14727-14733 (2019).
  21. Wu, H., et al. Enhanced Tumor Synergistic Therapy by Injectable Magnetic Hydrogel Mediated Generation of Hyperthermia and Highly Toxic Reactive Oxygen Species. ACS Nano. 13 (12), 14013-14023 (2019).
  22. Alzaraa, A., et al. Targeted microbubbles in the experimental and clinical setting. American Journal of Surgery. 204 (3), 355-366 (2012).

Przedruki i uprawnienia

Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE

Zapytaj o uprawnienia

Przeglądaj więcej artyków

Magnetic HyperthermiaPhotothermal TherapyTriple responsive MicrobubblesNanoparticle DeliveryCancer TreatmentAcoustic ResponseOptical ResponseNanoparticle Shelled MicrobubblesNanomedicine PlatformUltrasonic CleaningHomogenization ProcessFluorescence MicroscopyImaging TechniquesTherapeutic Synergy

This article has been published

Video Coming Soon

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone